You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemangiosarcoma

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microvessel Ultrasound Imaging for Detecting Extent of Disease

Recruiting
  • Skin Angiosarcoma
  • Ultrasound Microvessel Imaging
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 14, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023

Unresectable Angiosarcoma Trial in Tokyo (BNCT)

Recruiting
  • Unresectable Angiosarcoma
  • BNCT
  • Tokyo, Japan
    National Cancer Center Hospital
Nov 21, 2022

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),

Recruiting
  • Sarcoma
  • +2 more
  • Stanford, California
  • +1 more
Feb 2, 2023

Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

Recruiting
  • Locally Advanced Angiosarcoma
  • +2 more
  • Quality-of-Life Assessment
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Angiosarcoma of Skin Trial in Tampa (T-VEC)

Active, not recruiting
  • Angiosarcoma of Skin
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Angiosarcoma Trial in Amsterdam (Propranolol)

Recruiting
  • Angiosarcoma
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek
Dec 20, 2021

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Angiosarcoma of Skin Trial in Worldwide (Oraxol)

Active, not recruiting
  • Angiosarcoma of Skin
  • New York, New York
  • +9 more
Jan 31, 2023

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn
  • Angiosarcoma
  • (no location specified)
Dec 21, 2021

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

    Completed
    Has Results
    • Adult Angiosarcoma
    • +3 more
    • pazopanib hydrochloride
    • +4 more
    • Chicago, Illinois
    • +4 more
    Jul 26, 2022

    Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +18 more
    • Basking Ridge, New Jersey
    • +6 more
    May 18, 2023

    Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

    Completed
    Has Results
    • Adult Angiosarcoma
    • +3 more
    • Santa Monica, California
    • +6 more
    Mar 29, 2022

    Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

    Terminated
    Has Results
    • Angiosarcoma
    • Pazopanib + Paclitaxel
    • Graz, Austria
    • +9 more
    Jan 21, 2022

    Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

    Recruiting
    • Bone Sarcoma
    • +6 more
    • Treatment by Regorafenib
    • Treatment by Placebo
    • Besançon, France
    • +15 more
    Aug 18, 2022

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023

    Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

    Recruiting
    • Advanced Cancer
    • +7 more
    • Scottsdale, Arizona
    • +14 more
    Sep 15, 2022

    Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

    Recruiting
    • Metastatic Angiosarcoma
    • +7 more
    • Durvalumab
    • Oleclumab
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2021

    Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

    Withdrawn
    • Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Jul 26, 2021